Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020
November 24 2020 - 04:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced that it will report
financial results for the second quarter of fiscal year 2021 on
December 2, 2020 after market close and will host a conference
call and webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
Members of Avid's senior management will discuss financial results
for the second quarter and review recent corporate developments.
To listen to the live webcast, or access the
archived webcast, please visit:
http://ir.avidbio.com/investor-events.
To listen to the conference call, please dial
(877) 312-5443 or (253) 237-1126 and request the Avid Bioservices
call.
About Avid
Bioservices, Inc.Avid
Bioservices is a dedicated contract development and
manufacturing organization (CDMO) focused on development and CGMP
manufacturing of biopharmaceutical drug substances derived from
mammalian cell culture. The company provides a comprehensive range
of process development, CGMP clinical and commercial manufacturing
services for the biotechnology and biopharmaceutical industries.
With 27 years of experience producing monoclonal antibodies and
recombinant proteins, Avid's services include CGMP clinical and
commercial drug substance manufacturing, bulk packaging, release
and stability testing and regulatory submissions support. For
early-stage programs the company provides a variety of process
development activities, including upstream and downstream
development and optimization, analytical methods development,
testing and characterization. The scope of our services ranges
from standalone process development projects to full development
and manufacturing programs through commercialization.
www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Mar 2023 to Mar 2024